Aboca now features in the prestigious ALES - MERCO ranking of the 100 Italian companies with the best reputation. Specifically, Aboca ranked 56th in the table, with a score of 5.494 (on a scale of 1 to 10) and was the 4th highest company in the “Pharmaceutical and devices” industry.
This is the first edition of the corporate reputation survey in Italy by the independent institute Ales Market Research, an organisation with 20 years’ experience in market research. The analysis was conducted using the MERCO methodology, the world’s only reputation monitor verified by an external body. It is based on the opinion of directors, managers, experts from the corporate world, financial analysts, business journalists, NGO leaders, social media managers and consumers.
The complete list and further details are available on the AlesResearch website.
Following its transition into a Benefit Corporation, Aboca receives B Corp® certification. The market leader in therapeutic innovation using natural molecular complexes joins the movement that globally promotes and adopts a new business paradigm for environmental sustainability and the Common Good.
Read more
With the "Green Deal", Europe has placed sustainability at the very heart of its scientific, cultural and economic development.
Read more
Dopo il grande successo della prima edizione, torna la raccolta punti Aboca.
Dal 16 ottobre 2023 al 1 ottobre 2024 sarà di nuovo attiva “Aboca Life Collection”.
